Sensidose AB Stock

Stocks

23-05-24	Navamedic ASA (OB:NAVA) completed the acquisition of Sensidose AB.	CI
23-05-16	EQL Pharma AB cancelled the acquisition of all the remaining stake in Sensidose AB.	CI
23-05-05	Sensidose AB Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
23-04-24	Sweden’s EQL Pharma Increases Bid for Sensidose	MT
23-04-24	Navamedic Raises Takeover Offer for Sensidose, Agrees to Buy 57% Stake	MT
23-04-20	EQL Pharma Launches SEK91 Million Takeover Bid for Sensidose	MT
23-04-19	EQL Pharma AB made an offer to acquire all the remaining stake in to acquire Sensidose AB for SEK 91.7 million.	CI
23-03-28	Navamedic ASA (OB:NAVA) made an offer to acquire Sensidose AB for SEK 96 million.	CI
23-02-16	Sensidose AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	CI
23-02-16	Sensidose AB Reports Earnings Results for the Full Year Ended December 31, 2022	CI
23-02-08	Certain Shares of Sensidose AB are subject to a Lock-Up Agreement Ending on 9-FEB-2023.	CI
22-11-10	Sensidose AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	CI
22-05-12	Sensidose Starts Trading on Sweden's Spotlight Stock Market	MT

23-05-31	Updated recommendation by the nomination committee of Navamedic ASA	AQ
23-05-26	Navamedic to own a total of 96.33 per cent of shares in Sensidose following closing of public offer	AQ
23-05-26	Navamedic announces the final outcome in the offer to the shareholders and holders of warrants of series TO 1 in Sensidose Aktiebolag	AQ
23-05-17	EQL Pharma AB publishes the final outcome in public takeover offer. As a result of the shareholder dynamics and other circumstances the Board also announces its intention to sell its holdings.	AQ
23-05-11	Navamedic ASA Q1 2023: Another strong quarter	AQ